PROTOCOL NRG-BR002 – Temporarily Closed to Accrual

NRG-BR002, “A Phase IIR/III Trial of Standard of Care Therapy with or without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer,” will temporarily close to accrual at 5 PM ET today, Friday, September 13, as the trial has completed accrual to the phase IIR portion of the trial and is pending the full phase IIR primary endpoint analysis, per the protocol-specified statistical analysis plan.

 

The trial will be temporarily closed until the full number of events are reached for the phase IIR primary endpoint analysis and a decision is made as to whether or not the trial will continue to the phase III portion.  A broadcast regarding reopening will be sent after that decision is made.

Twitter
This message was sent to shepardm@nrgoncology.org by NRG-Broadcasts@NRGOncology.org
Four Penn Center 1600 JFK Blvd. Suite1020 , Philadelphia, PA, 19103


Unsubscribe from all mailings Unsubscribe | Manage Subscription | Forward Email | Report Abuse